Brenner EJ published “Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients with Inflammatory Bowel Diseases: Results from an International Registry (31)” in 2020 in Gastroenterology. This evidence concerns the gene TNF and inflammatory bowel disease.